Skip to main content
All lobbying filings

DRUG POLICY ALLIANCE

Lobbying for DRUG POLICY ALLIANCE

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$21,013.46
What this organization spent lobbying with its own staff. Reported using B: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New York

Official filing document

 Lobbyists on this filing 1
  • HANNA SHARIF-KAZEMI
    Previously held: Policy Manager

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Bills named in this filing 7
 Lobbying activity 3
Law Enforcement/Crime/Criminal Justice

We led a coalition to oppose passage of the HALT Fentanyl Act(H.R. 27 / S. 331) in Congress. We urged Congress to re-introduce the MORE Act (118th Congress - H.R. 5601).

Civil Rights/Civil Liberties

We led coalitions in support of the RESTORE Act (118th Congress - S. 1753/H.R. 3479), a bill that would get rid of the SNAP drug felony ban, and the Thurmond Amendment via a bill called the Fair Future Act (118th Congress - H.R. 9694/S. 5111).

Health Issues

We urged Congress to fully fund health programs that support people struggling with addiction in Congressional spending bills. We opposed OBBBA (H.R.) 1 and its cuts to Medicaid, SNAP, and public health programs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem